Evidence-Based Medicine Guidelines
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients. Accessed March 23, 2025.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
ID - 1305202
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
